<unk> , sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.<unk>  is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.<unk>  was approved for medical use in the United States in 2002.
Fulvestrant
Salvestrol
Tamoxifen
Anastrozole
N-Desmethyltamoxifen
Goserelin
Exemestane
Endoxifen